Abstract: (E)-N'-Benzylidene-7-methyl-2-propyl-1H-benzo [d]imidazole-5-carbohydrazides (5a-r) have been synthesized from 7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazide (3) by condensing with different aromatic aldehydes (4a-r). Title compounds (5a-r) were evaluated for in vitro antioxidant activity and based on their potential for antioxidant property, selected compounds 5d and 5m-p were screened for in vivo anti-inflammatory and analgesic activity. The results indicate that the compound 5o and 5p are effective against anti-inflammatory and analgesic activity. The biological data was further supported by molecular docking studies, which revealed the binding pattern and the affinity of the molecules in the active site of COX-2.
Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are considered as one of the most widely used therapeutics to alleviate pain and inflammation, especially arthritis. Most of the currently available NSAIDs have limitations for therapeutic uses, as they cause gastrointestinal and other side effects which are inseparable from their pharmacological activities. This prompts us for identification of lead structures that may be useful in designing new, potent drugs with less toxic effects [1, 2] .
5-Substituted benzimidazoles are privileged heterocycles for medicinal chemists due to their broad range of biological activities such as anti-inflammatory [3] , anticancer [4] and more specifically benimidazole-5-carboxylic acid and its derivatives are promising agents for hepatitis C virus infections [5, 6, 7] , Glycoprotein IIb/ IIIa inhibitors [8] , Glutaminyl Cyclase inhibitors [9] , and checkpoint kinase inhibitor [10] activities. Further the hydrazones plays a key role in medicinal chemistry due to the azomethine (-NH-N=CH-) connected with carbonyl group, and is responsible for different pharmaceutical applications, such as anti-inflammatory [11, 12] , anticancer [13] , antiviral [14] , anticonvulsant [15] , antiprotozoal [16] , antimalerial [17] , antileshmenial [18] , antiamoebic [19] , antimicrobial [20] , and analgesic [21] activity. Based on the pharmacological activities of both the benzimidazoles and hydrazones, and our quest in search of new biologically active molecules [22] [23] [24] , herein, we report the design, synthesis, antioxidant, anti-inflammatory and analgesic activity of (E)-N'-Benzylidene-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazides (5a-r).
Results and discussion

Chemistry
The synthesis of target molecules was achieved as outlined in scheme-1. The reaction sequences for the synthesis 5a: Ar = C 6 H 5 ; 5b: Ar = 4-OCH 3 C 6 H 4 ; 5c: Ar = 2-OH C 6 H 4 ; 5d: Ar = 3-ClC 6 H 4 ; 5e: Ar = 3-BrC 6 H 4 ; 5f: Ar = 3-OCH 3 C 6 H 4 ; 5g: Ar = 3,4-(OCH 3 ) 2 C 6 H 3 ; 5h: Ar = 4-CNC 6 H 4 ; 5i: Ar = 2-furyl; 5j: Ar = 2-thienyl; 5k: Ar = 1-napthyl; 5l: Ar = 2-CH 3 C 6 H 4 ; 5m: Ar = 4-NO 2 C 6 H 4 ; 5n: Ar = 5-Br,2-OHC 6 H 3 ; 5o: Ar = 2,4-(Cl) 2 ,C 6 H 3 ; 5p: Ar = 3,5-(Cl) 2 ,2-OHC 6 H 2 ; 5q: Ar = 4-OH C 6 H 4 ; 5r: Ar =4-OH, 3-OCH 3 C 6 H 3
Scheme 1 Synthesis of (E)-N'-benzylidene-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazides (5a-r).
of target hydrazones (5a-r), starts from methyl 4-butyriamido-3-methyl-5-nitrobenzoate (1) [25] , which underwent reductive cyclisation to yield methyl 7-methyl-2-n-propyl-1H-benzo[d]imidazole-5-carboxylate (2) [26] . In the process, compound-1 was reduced with Na 2 S 2 O 4 in water to afford methyl 3-amino-4-butyriamido-4-methylbenzoate, which in turn internally cyclised by nucleophilic addition of amino group to the adjacent amide carbonyl to form compound-2. The resulting methyl ester (2) was treated with hydrazine hydrate to afford acid hydrazide (3), which was confirmed by the stretching frequencies of NH and NH 2 in the IR spectrum at 3463, 3319, 3292 cm
H NMR spectrum of (3) displayed two singlets at δ 4.49 and δ 9.78 ppm corresponding to NH 2 and NH protons of acid hydrazide respectively. The title compounds (5a-r) were prepared by condensing the acid hydrazide with various aromatic aldehydes (4a-r) in methanol in the presence of catalytic amount of glacial acetic acid under reflux conditions. The target hydrazones (5a-r) were confirmed by IR, 1 H NMR, 13 C NMR and Mass spectral data. In the 1 H NMR spectrum of 5a, absence of NH 2 signal at δ 4.49 ppm and appearance of new singlet due to azomethine proton (-CH=N-) at δ 8.51 ppm confirms the structure of 5a.
Further the molecular ion [M+H]
+ at m/z 321 in the mass spectrum of 5a confirms its structure.
Reagents and conditions: (i) Na 2 S 2 O 4 , H 2 O, reflux, 4 h, 86% (ii) N 2 H 4 -H 2 O, ethanol, reflux, 10 h, 90% (iii) Ar-CHO (4a-r), gla.AcOH, MeOH, reflux, 4-6 h, 88-92%
Antioxidant Activity
The benzimidazolyl hydrazones (5a-r) have been screened for their in vitro antioxidant activity. The results indicates that the compound 5n has shown potent antioxidant activity with IC 50 value of 9.40±1.04 µg/mL, followed by compounds 5o, 5m, 5p and 5d with the IC 50 values of 12.39±1.26, 13.60±1.37, 16.27±1.37 and 18.31±1.38 µg/mL respectively. Rest of the compounds 5a-c, 5e, 5f-l, 5q and 5r have shown moderate to good antioxidant activity ( Table 1 ). The selected compounds 5d and 5m-p were further screened for their anti-inflammatory and analgesic activity.
Anti-inflammatory activity
The title compounds 5d and 5m-p were screened for their anti-inflammatory and analgesic activity based on their potential for antioxidant property. The tested compounds showed good to excellent anti-inflammatory activity in terms of decreased paw volume as shown in table 2. The compounds 5d and 5m-p exhibited the anti-inflammatory activity in the range of 25 
Molecular docking studies
The crystal structure of Cyclooxygenase-2 (COX-2, prostaglandin synthase-2) from mouse has been selected for molecular docking [27] and carried out the docking studies of 5d, 5m-5p and the reference molecule indomethacin with COX-2 protein. The indomethacin was also used as reference standard in the in vivo experimental analysis of anti-inflammatory activity of the synthesised molecules and hence selected the COX-2 protein with indomethacin for protein ligand binding analysis in the present study. All the selected five molecules have same core and differentiate at the phenyl substitutions showed similar binding conformations toward COX-2 protein. The crystal structure of PDB_ID:4COX contains a "heme" and indomethacin molecule in the active site. To validate the docking software, we have docked the indomethacin in to the same binding pocket of COX-2, and obtained the same result with similar orientation and minimal root mean square deviation (RMSD). The binding structure Table 2 ). The other compounds showed good to moderate anti-inflammatory activity. The results indicate that the presence of electron withdrawing groups like halogens and nitro on phenyl ring is playing a crucial role in the activity. of indomethacin and docked molecules orientations are shown in figure 1. All the five docked molecules have the core benzimidazole ring stabilized by cation-pi interactions with side chain NH of Arg-120 and aromatic ring of benzimidazole in the active site, and the other residues Val-349 and Ala-527 are forming CH-pi interactions. Further, the Nitrogen atom of the amide in all molecules, except 5n, is forming a hydrogen bond with side chain NH of Arg-120 and all the molecules are stabilized by hydrophobic interactions in the active site. The substituted aromatic phenyl group is also forming CH-pi interactions with side chain of both Leu-93 and Val-116 residues. The halogens (Chlorine and Bromine) on the phenyl ring are acting as electron withdrawing group and showing as anion character to make anion-pi interactions. These anion-pi interactions are as strong as hydrogen bond interactions [28] . The molecules 5d, 5m, 5o, and 5p having halogens showing the good anti-inflammatory activity in the experiment, where the halogens are interacting with the aromatic amino acids by forming anion-pi interactions with Phe-357, Tyr-115 and Trp-100 in the active site. The molecules 5n and 5p with hydroxyl substitution on phenyl ring decreasing the activity when compared with the halogen containing aromatic rings. The hydroxyl group become more acidic and easily loose the hydrogen, and the oxygen anion and the halogen can involve in the resonance with aromatic ring. This will cause decrease in the activity of the molecule. From the docking studies, we have identified the binding energies and molecular binding orientation of the test molecules in the active site. The data is enclosed in the table 4 and the docking procedure of Autodock vina in reproducing the experimental binding affinity seems reliable, and therefore predicted as true positive.
Conclusions
In the present study, the target hydrazone derivatives (5a-r) have been synthesized and their structures are established with the aid of IR, 1 H NMR, 13 C NMR and mass spectral data. All the synthesized compounds were evaluated for in vitro antioxidant activity, and the results showed compounds 5d, and 5m-p are more potent among the tested compounds. The highly active compounds from the antioxidant activity profile (5d, and 5m-p) were further evaluated for in vivo anti-inflammatory and analgesic activity and the from the results, the compound 5o found to be the most effective against anti-inflammatory activity and analgesic activity. In understanding the SAR of the target compounds and based on the results, substituted halogen derivatives exhibited the potent biological activities, the hydroxy along with halogen substituted compounds exhibited moderate biological activities due to extended resonances. The docking results aid in understanding the interaction pattern in the active site and their binding affinities of all the tested compounds, further the results proved that the di-halo substitution at o-and p-positions is crucial for exhibiting the best activity.
Experimental
All the melting points were determined on a Cintex melting point apparatus and are uncorrected. Analytical TLC was performed on Merck precoated 60F 254 silica gel plates and visualization was done by exposing to UV Light. IR Spectra (KBr Pellet) was recorded on a PerkinElmer BX series FT-IR Spectrometer.
1 H NMR (500 and 400 MHz) and 13 C NMR (125 and 100 MHz) spectra were recorded on a Bruker spectrometer in DMSO-d 6 with TMS as internal standard. ESI mass spectra were recorded on an Agilent LC-MSD mass spectrometer. Elemental analyses were performed on a Carlo Erba 106 and Perkin-Elmer model 240 analysers. All the chemicals were procured from Sigma Aldrich and are used as such without further purification.
Synthesis of 7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazide (3)
A mixture of methyl 2-n-Propyl-7-methyl-benzimidazole-5-carboxylate 2 (0.1 mmol) in ethanol (20 mL) and hydrazine hydrate (0.5 mmol) (98%) was heated for reflux for 10 h, and the progress of the reaction was monitored by TLC (10% Methanol in Dichloromethane). The reaction mixture was cooled to room temperature and the total volume of reaction mass reduced to half under reduced pressure and further cooled to 0-5°C. -N'-((naphthalen-2-yl) 
(E)-N'-(2-Hydroxybenzylidene)-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazide (5c)
(E)-N'-(3-Chlorobenzylidene)-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazide (5d)
(E)-N'-(3-Bromobenzylidene)-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazide (5e)
(E)-N'-(3-Methoxybenzylidene)-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazide (5f)
(E)-N'-((Furan-2-yl)methylene)-7-methyl-2-propyl-1H-benzo[d]imidazole-5-carbohydrazide (5i)
Yield
(E)-7-Methyl
7-Methyl-N'-[(E)-(2-methylphenyl)methylidene]-2-propyl-1H-benzimidazole-5-carbohydrazide (5l)
Antioxidant activity
The in vitro antioxidant activity has been evaluated by 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging test following the literature protocol [29] . The free radical scavenging activities of 5a-r were measured by DPPH with slightly modified spectrophotometric method. A solution of DPPH in methanol (6 × 10 -5 M) was prepared freshly and 3 mL aliquot of this solution was mixed with l mL of the samples at varying concentrations. The solutions in the test tubes (5a-r) were shaken well and incubated in the dark for 15 min at room temperature. The decrease in absorbance was measured at 517 nm. Ascorbic acid was used as the reference material. All the tests were performed in triplicate and the graph was plotted with the mean values. The percentage of inhibition was calculated by comparing the absorbance values of the control and test samples. The percentage inhibition was calculated by using the formula, % Inhibition = [( A control -A sample ) /A control ] × 100.
Anti-inflammatory Activity
The in vivo anti-inflammatory activity was determined by carrageenan-induced paw edema method [30] . Wistar rats of either sex weighing 150-200 g were divided into 6 groups (n = 6). They were fasted for 18 h before the experiment with water ad libitum. The groups of rats administered with 0.5 % DMSO (negative control), indomethacin at a dose of 10 mg/kg (positive control), and test samples at 10 mg/kg. All the compounds were administered in an oral route and after 30 min, 0.1 mL of 1 % carrageenan suspension in normal saline was injected into the subplantar region of the left hind paw of each rat to induce edema. The edema volumes of the injected paw were measured with the help of plethysmograph at an interval of 0, 1, 2, 4, and 6 h. The difference between the paw volumes of treated animals were compared with that of the control group and the mean edema volume was calculated. Percentage inhibition was calculated as per the formula, %Inhibition = [V o -V t / V o ] × 100, where V o = volume of the paw control at time t, V t = volume of the paw of drug treated at time t.
Analgesic activity
The in vivo analgesic activity test was conducted using the hot-plate method [31, 32] . Albino mice weighing 20-30 gm were divided into eleven groups of six in each group. The temperature on hot plate is controlled at 55 ± 10 o C. The animals were placed on the plate on the heated surface and the time (sec) to discomfort reaction (licking paws or jumping) was recorded as response latency period at time interval of 30, 60, 90, 120 and 180 min following oral administration of the standard and the test compounds. A latency period of 45 sec was identified as complete analgesia and the measurement was terminated if it exceeded the latency period in order to avoid injury.
Molecular docking studies:
Molecular modelling studies of five selected compounds were carried out using Autodock vina software [33] and docking of all compounds was carried out on cyclooxygenase-2 complexed with indomethacin (PDB_ID 4COX, chain A). This protein PDB was retrieved from protein data bank. During the docking studies, we have used 1Å grid box parameters as centre: x=22.741, y=23.808, z=15.008 and grid box size: x=20, y=22, z=22 and while docking 20 conformations were generated for each ligand by using default genetic algorithm. In the present study, input preparation carried out using MGL tools-1.5.6 and final docking performed in Autodock vina.
